The Glaucoma Research Foundation (GRF) was created to encourage innovative research to find better ways to care for people with glaucoma — the leading cause of preventable blindness.
Glaucoma 360 is a series of three days of annual events uniting research, industry, and philanthropy to prevent vision loss from glaucoma and speed the cure.
The mission of AAPOS is to promote the highest quality medical and surgical eye care worldwide for children and for adults with strabismus.
The American Macular Degeneration Foundation works for the prevention, treatment, and cure of macular degeneration through raising funds, educating the public, and supporting scientific research.
The Eye Guru's mission is to accelerate ophthalmology training by efficiently delivering high yield, well organized ophthalmic knowledge.
Eye News TV produces and distributes eye care videos related to doctors and patients. Doctors learn from Key Opinion Leaders and patients can from doctors as well as learn about eye MD technologies.
The urgent mission of the Foundation Fighting Blindness is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration, Usher syndrome and the entire spectrum of retinal degenerative diseases.
The mission of Juliette RP Vision Foundation is to provide scholarships for visually impaired children who are destined for college and U.S. ophthalmology resident physicians who are interested in pursuing research and/or clinical practice in the area of Retinitis Pigmentosa
Ophthalmology Business Minute™: A series of resources designed to help ophthalmology residents and fellows primarily and younger ophthalmologists with the business side of ophthalmology.
WIO: Enhancing and improving the professional environment for women ophthalmologists.
World Orphan Drug Congress: The largest rare disease and orphan drug conference globally brings together leading industry, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers who rely on World Orphan Drug Congress USA to meet, brainstorm and dialogue on ways to advance orphan drug development and improve access to life-saving therapies — all without having to leave their homes.